Skip to main content

Peer Review reports

From: Immunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years: an open-labeled, single-arm clinical trial

Original Submission
25 Jul 2023 Submitted Original manuscript
13 Nov 2023 Reviewed Reviewer Report
23 Feb 2024 Reviewed Reviewer Report
8 Mar 2024 Author responded Author comments - Lihui Gong
Resubmission - Version 2
8 Mar 2024 Submitted Manuscript version 2
18 Mar 2024 Author responded Author comments - Lihui Gong
Resubmission - Version 3
18 Mar 2024 Submitted Manuscript version 3
1 Apr 2024 Reviewed Reviewer Report
4 Apr 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
4 Apr 2024 Editorially accepted
19 Apr 2024 Article published 10.1186/s12879-024-09293-1

You can find further information about peer review here.

Back to article page